Denmark · Investor

Lundbeckfonden Ventures

Last cheque observed May 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BAnalyticsHuman ResourcesBiotechnology

Cheques on record
0%of best year0cheques in 12 months, 7 on record
Since the last cheque2716days00hrs00min00sec
Median round$31MRounds led0 of 7Sole investor1 roundsMostly inUnited States, 57%
Pitch Lundbeckfonden Ventures

Lundbeckfonden Ventures highlights

  1. 01

    7 rounds on record

  2. 02

    Mostly Series A and Series C: 80% of its rounds

  3. 03

    Sole investor in 1 rounds, median $23M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
AnalyticsHuman ResourcesBiotechnology
Based in
Copenhagen, Denmark
Cold pitches
Not accepted

The record

Every round we can evidence, newest first7 appearances

  1. 2019

    2 rounds

  2. May
    Reneo PharmaceuticalsSeries A · US · FinSMEs$50MWith 3 others
  3. Jan
    Tiburio TherapeuticsSeries A · US · FinSMEs$31MWith 3 others
  4. 2018

    1 round

  5. Aug
    Dysis MedicalGB · FinSMEs$23MSole investor
  6. 2017

    4 rounds

  7. Dec
    Aura BiosciencesSeries C · US · 4-traders$30MWith 9 others
  8. Dec
    Atox BioIL · FinSMEs$30MWith 6 others
  9. Mar
    Spero TherapeuticsSeries C · US · FinSMEs$52MWith 8 others
  10. Jan
    EnteromeSeries D · FR · FinSMEs$39MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Lundbeckfonden Ventures. A count of rooms they were both in, not a relationship either has claimed.

Alexandria Real Estate EquitiesVC firm2rounds togetherNew Enterprise AssociatesVC firm2rounds togetherSR OneCorporate VC2rounds together

Recently backed

The latest companies Lundbeckfonden Ventures put money into.

Spero Therapeutics$52M · Mar 2017Enterome$39M · Jan 2017

Quick answers about Lundbeckfonden Ventures

What does Lundbeckfonden Ventures invest in?

Lundbeckfonden Ventures invests most often at Series A and Series C (80% of the rounds on record), in sectors such as Analytics, Human Resources and Biotechnology.

How active is Lundbeckfonden Ventures?

7 investments on record, 0 of them in the last 12 months. The most recent was in May 2019.

What has Lundbeckfonden Ventures invested in recently?

Its most recent investments on record: Reneo Pharmaceuticals (Series A, May 2019), Tiburio Therapeutics (Series A, Jan 2019) and Dysis Medical (Undisclosed round, Aug 2018).

How big are Lundbeckfonden Ventures's cheques?

The median round it joins is $31M.

Does Lundbeckfonden Ventures lead rounds?

Rarely, if at all: none of its 7 investments on record names it as the lead.

Where does Lundbeckfonden Ventures invest?

Most of the companies it backs are in the United States (57%), the United Kingdom (14%) and Israel (14%).

Is Lundbeckfonden Ventures investing now?

No investments in the last 12 months; the latest was in May 2019.

Who does Lundbeckfonden Ventures invest alongside?

Most often Alexandria Real Estate Equities (2 rounds together), New Enterprise Associates (2 rounds together) and SR One (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it